MelaTech is an early-stage biotechnology company, founded in 2017, with the slogan "Unlocking Melanin's Potential for Global Innovation". The company's mission is to develop and mass manufacture melanin-based biomaterials for radiation shielding and energy capture applications. They specialize in the sustainable production of natural melanins using microorganisms as a cost-effective alternative to scarce animal and plant sources. Their melanin preparations exhibit unique physical-chemical properties and can be tailored to specific applications. Based in the United States, MelaTech operates within the industries of biotechnology, energy, internet, and telecom. As of now, there is no public information regarding the company's last investment and the investors involved.
There is no investment information
No recent news or press coverage available for MelaTech.